Balance Sheets (Current Period Unaudited) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Assets
Cash and cash equivalents	$ 83,767	$ 409,039
Accounts receivable	751
Inventory	3,452	4,131
Prepaid expense and other current assets	69,960	32,125
Total current assets	157,930	445,295
Patents, net	139,774	146,263
Property and equipment, net	3,576	5,068
Total assets	301,280	596,626
Liabilities and Stockholders' Equity (Deficit)
Accounts payable and accrued expenses	359,996	208,727
Advances from investors	85,000	100,000
Convertible notes payable – related party	632,814	444,581
Total current liabilities	1,077,810	753,308
Total liabilities	1,077,810	753,308
Stockholders' equity (deficit)
Preferred stock, $0.01 par value: Authorized shares - 10,000,000, Issued and outstanding shares – 0 at September 30, 2020 and December 31, 2019
Common stock, $0.01 par value: Authorized shares - 100,000,000, Issued and outstanding shares –40,916,351 and 40,516,351 at September 30, 2020 and December 31, 2019, respectively	409,164	405,164
Additional paid-in capital	4,586,068	4,207,786
Accumulated deficit	(5,771,762)	(4,769,632)
Total stockholders’ equity (deficit)	(776,530)	(156,682)
Total liabilities and stockholders’ equity (deficit)	$ 301,280	$ 596,626